谷氨胺载体作为消化系统恶性瘤治疗中的有效标
Fei Chu1, Kai Tong1, Xiang Gu1
1School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Oncology research
|September 23, 2024
概括
向谷氨胺载体可以抑制瘤生长. 本综述讨论了消化系统恶性瘤 (DSMT) 中的谷氨胺载体以及改善治疗的潜在药物疗法.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 谷氨酸是人类生物过程中必不可少的氨基酸.
- 瘤细胞在很大程度上依赖于谷氨胺的吸收,由上调运输体促进,以促进增殖.
- 消化系统恶性瘤 (DSMT) 的发病率和死亡率很高,需要新的治疗方法.
研究的目的:
- 审查涉及DSMT的谷氨胺载体.
- 阐明这些传送器在DSMT发展和进步中的作用.
- 讨论当前和新兴的DSMT治疗的谷氨胺载体向药物.
主要方法:
- 关于癌症中的谷氨酸代谢和运输的文献综述.
- 分析在DSMT中特定的谷氨胺载体的作用.
- 对针对谷氨胺载体的现有药物和试验药物的调查.
主要成果:
- 谷氨胺转运体在DSMT中受到上调,支持细胞快速生长.
- 抑制谷氨胺载体在减少瘤细胞增殖方面表现出有效性.
- 几种谷氨胺转运体抑制剂正在进行癌症治疗的研究.
结论:
- 向谷氨胺载体为DSMT提供了一个有前途的治疗策略.
- 对谷氨胺载体抑制剂的进一步研究可能会导致更有效的DSMT治疗方法.
- 这一审查为开发针对DSMT的新药提供了基础.
相关概念视频
Carrier-Mediated Transport
310
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
310
Secondary Active Transport
6.9K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
6.9K
Glucose Transporters
22.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Transcellular Transport of Solutes
3.5K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
3.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
153
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
153


